6th NovAliX Conference

2bind is the expert provider for biophysical analytical services in protein and RNA-targeted drug discovery as well as antibody development. 2bind offers tailor-made service solutions covering everything from high-throughput biophysical ligand screening to in-depth comprehensive ligand characterization.

Bruker is a global technology leader delivering innovative, integrated analytical instrumentation for use in the life science molecular research, applied & pharma applications, microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

Creoptix revolutionizes the study of molecular interactions: The combination of unparalleled sensitivity, crude sample robustness and a broad kinetic range now allow membrane protein studies in crude membranes, antibody-kinetics in pure serum or even plasma or accurate kinetic characterization of weak binders.

At the European Synchrotron (ESRF) and the Institut Laue Langevin (ILL), we help industry ''.chr('64257').''nd answers to their challenges through unique research facilities, which allow advanced material and device characterisation, either in-situ or in-operando, far beyond conventional laboratory capabilities.

FortéBio is a business unit of Molecular Devices LLC, offering products that span multiple technology vectors including analytical instrumentation and software, clone picking and imaging, and customized engineering solutions. We partner with our customers in biologics and other life sciences segments to unlock workflow bottlenecks, by providing best-in-class products, knowing the science behind our customers’ research, and providing first-class service.

I&L Biosystems GmbH was founded in 1991. Focus of I&L is on sales and distribution of high quality laboratory equipment to customers and researchers in microbiology, cell biology and biotechnology markets in Western Europe, United Kingdom and Scandinavia. 

Molecular Dimensions supplies modern screens, reagents and instrumentation for protein structure determination. It has alliances with leading scientists aimed at developing and commercializing innovative ideas. Anatrace develops and supplies high-purity detergents and lipids. It is an internationally-recognized leader in manufacturing reagents for membrane protein studies and custom chemical synthesis. 

NanoTemper Technologies is committed to the best customer experience and enabling researchers to easily, efficiently, and accurately characterize proteins. With systems, software and consumables for evaluating binding affinities, protein stability and protein quality, scientists in pharmaceutical, biotech or academia will find an optimized workflow, quality results and responsive customer support.

NovAliX is a drug discovery-focused CRO with several unique technologies. It is highly proficient in chemistry and biophysics. The company has set up one of the world’s most comprehensive biophysics platforms. Our commitment and reliability are much appreciated by a worldwide client base.

Reaction Biology Corporation is a CRO that specializes in compound profiling services for early drug discovery programs. Our mission is to be the premier provider of assay services. We offer a wide range of services, including biochemical, biophysical, electrophysiological and cell-based assays for high throughput screening and selectivity compound profiling. 

Synthelis is a French biotech specialized in production, purification and characterization of proteins and difficult-to-express proteins.

Thermo Fisher Scientific, the world leader in serving science, provides complete workflows, from cryo-EM structural determination of macromolecular complexes in native state to 3D reconstruction of tissues and cells. Our solutions help unlock mysteries of underlying protein function and cellular process, bridging the gap between basic science and translational therapeutics.

WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company, providing a broad and integrated portfolio of services to help our customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions.